Reduced viscosity protein pharmaceutical formulations
Abstract:
Described herein are therapeutic protein formulations comprising N-methyl pyrrolidone (NMP), methods related to reducing viscosity of pharmaceutical formulations and methods related to stabilizing pharmaceutical formulations using NMP.
Public/Granted literature
Information query
Patent Agency Ranking
0/0